Steven M. Rauscher

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA.

Target Discovery, Inc. provides scientific research services. It discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and the management of diseases. The firm’s products address prostate cancer aggressiveness, and chemotherapy selection in breast and ovarian cancer. The company was founded by Luke V. Schneider in 1999 and is headquartered in Palo Alto, CA.

Euromedica SA engages in the provision of healthcare solutions. It offers a range of services such as supplies, and technical support, medical diagnosis, hospitalization and cure. It operates through the Diagnostic Centers and Other Companies segments. The Diagnostic Centers segment provides disease prevention and diagnosis services without the need for hospitalization. The Other Companies segment includes specialized clinics that offer physiotherapy services, special physical education, neurophysiological monitoring, and evaluation programs. The company was founded in 1974 and is headquartered in Athens, Greece.

AmericasDoctor, Inc. provides healthcare services. It provides pharmaceutical services that combines and integrates physician researchers in conducting clinical research trials to assist the pharmaceutical industry in developing, positioning, and promoting its products. The company was founded on November 23, 1993 and is headquartered in Gurnee, IL.